Guangdong Jiaying Pharmaceutical Co Ltd (002198) — Financial Flexibility Index
Guangdong Jiaying Pharmaceutical Co Ltd (002198) has a Financial Flexibility Index of -0.27x as of September 2025. Free cash flow of CN¥-18.02 Million (operating CF CN¥-45.73 Million minus capex CN¥27.71 Million) represents 0% of total liabilities (CN¥65.72 Million). Check strategic asset allocation of Guangdong Jiaying Pharmaceutical Co Ltd to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Guangdong Jiaying Pharmaceutical Co Ltd Financial Flexibility Index (2004–2025)
Historical Financial Flexibility Index trend for Guangdong Jiaying Pharmaceutical Co Ltd across 22 annual periods. See Guangdong Jiaying Pharmaceutical Co Ltd working capital to net assets to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Guangdong Jiaying Pharmaceutical Co Ltd (2004–2025)
Year-by-year free cash flow to debt coverage for Guangdong Jiaying Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see Guangdong Jiaying Pharmaceutical Co Ltd market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.91x | CN¥118.93 Million | CN¥9.00 Million | CN¥131.30 Million | ▼ -26.7% |
| 2024 | 1.24x | CN¥99.55 Million | CN¥60.85 Million | CN¥80.60 Million | ▲ +0.9% |
| 2023 | 1.22x | CN¥103.51 Million | CN¥98.45 Million | CN¥84.58 Million | ▲ +384.0% |
| 2022 | 0.25x | CN¥29.89 Million | CN¥27.15 Million | CN¥118.23 Million | ▼ -42.6% |
| 2021 | 0.44x | CN¥54.14 Million | CN¥51.80 Million | CN¥122.85 Million | ▼ -49.1% |
| 2020 | 0.87x | CN¥108.55 Million | CN¥96.87 Million | CN¥125.43 Million | ▲ +424.9% |
| 2019 | 0.16x | CN¥31.78 Million | CN¥12.96 Million | CN¥192.77 Million | ▼ -75.8% |
| 2018 | 0.68x | CN¥71.05 Million | CN¥62.10 Million | CN¥104.21 Million | ▲ +76.2% |
| 2017 | 0.39x | CN¥49.07 Million | CN¥30.63 Million | CN¥126.80 Million | ▼ -32.0% |
| 2016 | 0.57x | CN¥65.11 Million | CN¥53.13 Million | CN¥114.38 Million | ▼ -11.1% |
| 2015 | 0.64x | CN¥75.73 Million | CN¥42.31 Million | CN¥118.30 Million | ▼ -45.5% |
| 2014 | 1.18x | CN¥202.10 Million | CN¥103.36 Million | CN¥171.94 Million | ▲ +356.1% |
| 2013 | 0.26x | CN¥28.18 Million | CN¥19.46 Million | CN¥109.35 Million | ▼ -21.3% |
| 2012 | 0.33x | CN¥11.85 Million | CN¥5.27 Million | CN¥36.17 Million | ▲ +2.1% |
| 2011 | 0.32x | CN¥11.56 Million | CN¥781.89K | CN¥36.04 Million | ▼ -75.4% |
| 2010 | 1.30x | CN¥55.32 Million | CN¥19.70 Million | CN¥42.40 Million | ▼ -85.2% |
| 2009 | 8.81x | CN¥104.93 Million | CN¥27.98 Million | CN¥11.91 Million | ▲ +97.1% |
| 2008 | 4.47x | CN¥39.77 Million | CN¥10.71 Million | CN¥8.89 Million | ▲ +443.5% |
| 2007 | 0.82x | CN¥27.02 Million | CN¥18.35 Million | CN¥32.85 Million | ▼ -21.7% |
| 2006 | 1.05x | CN¥39.32 Million | CN¥26.37 Million | CN¥37.42 Million | ▲ +18.9% |
| 2005 | 0.88x | CN¥23.72 Million | CN¥17.63 Million | CN¥26.84 Million | ▼ -24.4% |
| 2004 | 1.17x | CN¥26.83 Million | CN¥8.78 Million | CN¥22.95 Million | — |